Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | EOG | CNQ |
|---|---|---|
| Price | $142.49 | $48.05 |
| Change today | ▲ 0.46% | ▲ 0.85% |
| Market cap | $74.74B | $99.04B |
| Return, 3 months | +6.8% | +23.1% |
| Return, year to date | +39.1% | +46.1% |
| Return, 1 year | +26.3% | +52.8% |
| P/E (TTM) | 11.1 | 12.1 |
| P/B | 2.3 | 3.0 |
| P/E percentile vs own 5y | 65th | 52nd |
| Dividend yield | 2.83% | 3.56% |
| Revenue growth (YoY, latest qtr) | +58.6% | +77.9% |
| Net profit growth (YoY) | +102.5% | +83.1% |
| Gross margin | 65.4% | 26.3% |
| Operating margin | 35.4% | 23.2% |
| Net margin | 25.8% | 22.9% |
| Return on equity | 22.5% | 26.7% |
| Analyst target vs. price | +13.5% | +9.6% |
| Analyst buy share | 47% | 44% |
| RSI (14) | 45 | 46 |
| 30-day volatility | 28.8% | 26.4% |
| Max drawdown, 1 year | -15.0% | -21.5% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.